ERNEXA THERAPEUTICS INC.

Profile

Company Names

ERNEXA THERAPEUTICS INC.
ETERNA THERAPEUTICS INC.
BROOKLYN IMMUNOTHERAPEUTICS, INC.
NTN BUZZTIME INC

Addresses

1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA 02141

10355 SCIENCE CENTER DRIVE, SUITE 150, SAN DIEGO, CA 92121

140 58TH STREET, BUILDING A, SUITE 2100, BROOKLYN, NY 11220

2231 RUTHERFORD RD. #200, CARLSBAD, CA 92008

5966 LA PLACE COURT, SUITE 100, CARLSBAD, CA 92008

Phone Numbers

(617) 798-6700
(212) 582-1199
(760) 476-3543
760-438-7400

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER, TELECOMMUNICATIONS

Year Incorporated:

> 5 years ago

State Incorporated:

DE

Total Amount Raised:

$49,253,619.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2025-03-31 
$7,249,999.00 
$7,249,999.00 
$0.00 
Equity 
7
2024-09-24 
$1,137,746.00 
$1,137,746.00 
$0.00 
Equity 
6
2023-12-15 
$7,788,000.00 
$9,193,000.00 
$1,405,000.00 
Equity, Debt 
5
2023-07-14 
$8,715,000.00 
$8,715,000.00 
$0.00 
Equity, Debt 
4
2022-12-02 
$7,712,874.00 
$7,712,874.00 
$0.00 
Equity 
3
2022-03-09 
$12,000,000.00 
$12,000,000.00 
$0.00 
Equity 
2
2013-11-12 
$2,400,000.00 
$3,840,000.00 
$1,440,000.00 
Equity 
1
2009-05-11 
$2,250,000.00 
$2,250,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MATTHEW 
 
ANGEL 
EXECUTIVE OFFICER, DIRECTOR
TERRY 
 
BATEMAN 
DIRECTOR, EXECUTIVE OFFICER
JEFF 
 
BERG 
DIRECTOR, EXECUTIVE OFFICER
KENDRA 
 
BERGER 
EXECUTIVE OFFICER
BRANT 
 
BINDER 
DIRECTOR
BARRY 
 
CHANDLER 
EXECUTIVE OFFICER
PETER 
 
CICALA 
DIRECTOR
DOROTHY 
 
CLARKE 
DIRECTOR, EXECUTIVE OFFICER
KEVIN 
 
D-AMOUR 
EXECUTIVE OFFICER
ERIN 
S. 
ENRIGHT 
DIRECTOR
JOSEPH 
J. 
FARRICIELLI, JR. 
DIRECTOR
HOWARD 
J. 
FEDEROFF 
EXECUTIVE OFFICER, DIRECTOR
GREGORY 
 
FIORE 
DIRECTOR
SANDRA 
 
GURROLA 
EXECUTIVE OFFICER
ANDREW 
 
JACKSON 
EXECUTIVE OFFICER
KENNETH 
L. 
KEYMER 
DIRECTOR
VLADIMIR 
 
KHUCHUA-EDELMAN 
EXECUTIVE OFFICER
MARY BETH 
 
LEWIS 
DIRECTOR
SANJEEV 
 
LUTHER 
EXECUTIVE OFFICER, DIRECTOR
STEVE 
 
MITGANG 
DIRECTOR
KIRK 
 
NAGAMINE 
EXECUTIVE OFFICER
ELENA 
 
RATNER 
DIRECTOR
HEATHER 
B. 
REDMAN 
DIRECTOR
JAY 
 
SIAL 
EXECUTIVE OFFICER
ROGER 
 
SIDHU 
EXECUTIVE OFFICER
TONY 
 
UPHOFF 
DIRECTOR
RICHARD 
W. 
WAGNER 
DIRECTOR
WILLIAM 
 
WEXLER 
DIRECTOR
PAUL 
 
YANOVER 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2025-03-31 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2024-09-24 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Debt 
2024-09-24 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity, Debt 
2023-12-15 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2023-07-14 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2023-07-14 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-12-02 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-03-09 
D
OTHER 
TELEVISION BROADCASTING STATIONS [4833] 
$5,000,001 - $25,000,000 
Equity 
2013-11-12 
D
TELECOMMUNICATIONS 
TELEVISION BROADCASTING STATIONS [4833] 
$25,000,001 - $100,000,000 
Equity 
2009-05-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
CANTOR FITZGERALD + CO.
134
NONE
NONE
MAXIM GROUP LLC